Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
1. Molecular Target Drug DiscoveryInternal Medicine, 2007, Vol.46(2), pp.87-90 [Peer Reviewed Journal]2007 by The Japanese Society of Internal Medicine ;ISSN: 0918-2918 ;EISSN: 1349-7235 ;DOI: 10.2169/internalmedicine.46.1779 ;PMID: 17220605Full text available |
|
2 |
Material Type: Article
|
100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?Current topics in medicinal chemistry, 2012-08, Vol.12 (15), p.1643-1648 [Peer Reviewed Journal]ISSN: 1568-0266 ;DOI: 10.2174/156802612803531351Full text available |
|
3 |
Material Type: Article
|
10th antibody industrial symposium: new developments in antibody and adoptive cell therapiesmAbs, 2023-12, Vol.15 (1), p.2211692-2211692 [Peer Reviewed Journal]Attribution - NonCommercial ;2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2023.2211692 ;PMID: 37184206Full text available |
|
4 |
Material Type: Article
|
(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancerThe Journal of nuclear medicine (1978), 2007-08, Vol.48 (8), p.1357 [Peer Reviewed Journal]ISSN: 0161-5505 ;EISSN: 1535-5667 ;DOI: 10.2967/jnumed.106.037937 ;PMID: 17631548Full text available |
|
5 |
Material Type: Article
|
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose studyLancet neurology, 2010-04, Vol.9 (4), p.363-372 [Peer Reviewed Journal]2010 Elsevier Ltd ;2010 Elsevier Ltd. All rights reserved. ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(10)70043-0 ;PMID: 20189881Full text available |
|
6 |
Material Type: Article
|
131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: A Phase II Clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospitalCancer biotherapy & radiopharmaceuticals, 2003-08, Vol.18 (4), p.513-524 [Peer Reviewed Journal]2004 INIST-CNRS ;ISSN: 1084-9785 ;EISSN: 1557-8852 ;PMID: 14503945 ;CODEN: CBRAFJFull text available |
|
7 |
Material Type: Article
|
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroidsCancer research (Chicago, Ill.), 1989-06, Vol.49 (12), p.3401-3406 [Peer Reviewed Journal]1989 INIST-CNRS ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;PMID: 2720694 ;CODEN: CNREA8Full text available |
|
8 |
Material Type: Article
|
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy: Treatment outcome, haematological toxicity and bone marrow absorbed dose estimatesActa oncologica, 2002, Vol.41 (3), p.297-303 [Peer Reviewed Journal]2002 INIST-CNRS ;ISSN: 0284-186X ;ISSN: 1651-226X ;EISSN: 1651-226X ;DOI: 10.1080/02841860260088854 ;PMID: 12195750 ;CODEN: ACTOELFull text available |
|
9 |
Material Type: Article
|
131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor XenograftThe Journal of nuclear medicine (1978), 1999-10, Vol.40 (10), p.1764-1768 [Peer Reviewed Journal]1999 INIST-CNRS ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;PMID: 10520720Full text available |
|
10 |
Material Type: Article
|
131I-Rituximab: Relationship Between Immunoreactivity and Specific ActivityThe Journal of nuclear medicine (1978), 2004-10, Vol.45 (10), p.1784-1790 [Peer Reviewed Journal]ISSN: 0161-5505 ;EISSN: 1535-5667 ;PMID: 15471849Full text available |
|
11 |
Material Type: Article
|
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphomaMolecular imaging and biology, 2010-04, Vol.12 (2), p.198-203 [Peer Reviewed Journal]Academy of Molecular Imaging and Society for Molecular Imaging 2010 ;ISSN: 1536-1632 ;EISSN: 1860-2002 ;DOI: 10.1007/s11307-009-0245-9 ;PMID: 19543946Full text available |
|
12 |
Material Type: Article
|
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modelingThe Journal of nuclear medicine (1978), 2010-07, Vol.51 (7), p.1155-1162 [Peer Reviewed Journal]COPYRIGHT © 2010 by the Society of Nuclear Medicine, Inc. 2010 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;DOI: 10.2967/jnumed.110.075176 ;PMID: 20554734Full text available |
|
13 |
Material Type: Article
|
131I-Tositumomab Therapy as Initial Treatment for Follicular LymphomaThe New England journal of medicine, 2005-02, Vol.352 (5), p.441-449 [Peer Reviewed Journal]Copyright © 2005 Massachusetts Medical Society. All rights reserved. ;2005 INIST-CNRS ;Copyright 2005 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa041511 ;PMID: 15689582 ;CODEN: NEJMAGFull text available |
|
14 |
Material Type: Article
|
14th annual UCLA symposia. Monoclonal antibodies and cancer therapy. January 26-February 2, 1985. AbstractsJournal of cellular biochemistry. Supplement., 1985, Vol.9A, p.33-74 [Peer Reviewed Journal]ISSN: 0733-1959 ;PMID: 3856086Full text available |
|
15 |
Material Type: Article
|
16-Gy Low-Voltage X-ray Irradiation With Ranibizumab Therapy for AMD: 6-Month Safety and Functional OutcomesOphthalmic surgery, lasers & imaging retina, 2011-11, Vol.42 (6), p.468-473 [Peer Reviewed Journal]ISSN: 2325-8160 ;EISSN: 2325-8179 ;DOI: 10.3928/15428877-20110804-01Full text available |
|
16 |
Material Type: Article
|
177 Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin LymphomaJournal of Nuclear Medicine, 2020-10, Vol.61 (10), p.1468-1475 [Peer Reviewed Journal]2020 by the Society of Nuclear Medicine and Molecular Imaging. ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.119.237230 ;PMID: 32245896Full text available |
|
17 |
Material Type: Article
|
1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, IsraelmAbs, 2012-07, Vol.4 (4), p.426-433 [Peer Reviewed Journal]EISSN: 1942-0870 ;DOI: 10.4161/mabs.20289 ;PMID: 22664457Full text available |
|
18 |
Material Type: Article
|
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximabArthritis research & therapy, 2007-01, Vol.9 (3), p.R61-R61 [Peer Reviewed Journal]COPYRIGHT 2007 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2007 Marotte et al.; licensee BioMed Central Ltd. 2007 Marotte et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2219 ;PMID: 17597527Full text available |
|
19 |
Material Type: Article
|
A 12-week-old male with a 10-day history of feverPediatric annals, 2014-05, Vol.43 (5), p.e111-e115 [Peer Reviewed Journal]Copyright 2014, SLACK Incorporated. ;Copyright 2014, SLACK Incorporated ;ISSN: 0090-4481 ;EISSN: 1938-2359 ;DOI: 10.3928/00904481-20140417-09 ;PMID: 24877492Full text available |
|
20 |
Material Type: Article
|
A 16-year-old girl with perianal skin tagsPediatric annals, 2012-06, Vol.41 (6), p.10-12 [Peer Reviewed Journal]Copyright 2012, SLACK Incorporated ;ISSN: 0090-4481 ;EISSN: 1938-2359 ;DOI: 10.3928/00904481-20120525-10 ;PMID: 22694227Full text available |